MMF is a lymphocyte inhibitor and it is well tolerates by teenagers, so it has become common in the treatment can effectively control the active disease and induce remission in patients with CTD-ILD. More importantly, it can also avoid the need for high doses and prolonged therapy with corticosteroids, thereby bypassing severe long-term toxicity in young patients.